I

iBio

D
IBIO
USD
-0.003
(-0.118%)
Market Closed
2,195.00
Volume
-7.74
EPS
-
Div Yield
-0.630273
P/E
21,940,253.30
Market Cap
Today
-0.1180%
1 Week
-2.682%
1 Month
-3.422%
6 Months
24.510%
12 Months
-57.975%
Year To Date
84.058%
All Time
0%

Title:
iBio

Sector:
Healthcare
Industry:
Biotechnology
iBio Inc is a part of the healthcare sector. Its main business is commercialized technologies and product candidates and manufacturing services to clients and collaborators. Its main area of business is plant-based protein expression technologies for vaccines and therapeutic proteins and developing and commercializing select biopharmaceutical product candidates. Its products are used to combat various areas such as fibrotic diseases, cancers, and infectious diseases. The company operates in two segments: Biopharmaceuticals and Bioprocessing activities, conducted within iBio, Inc. and CDMO segment, conducted within iBio CDMO.
Do you need help or have a question?